Tools

LEADER 03543nam a2200565 i 4500

001 on1452769138;

003 OCoLC;

005 20241021155117.0;

006 m o d f ;

007 cr b|||||a||||;

008 240820s2024 dcua ob f000 0 eng c;

024 8 a| 55-967q| (GPO jacket number);

035 a| (Sirsi) o1452769138;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:118-35;

088 a| Serial no. 118-35 (United States. Congress. House. Committee on Energy and Commerce);

245 10 a| Examining the root causes of drug shortages :b| challenges in pharmaceutical drug supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, May 11, 2023.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2024.;

300 a| 1 online resource (v, 88 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "Serial no. 118-35.";

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Alex Oshmyansky, M.D., Ph.D., Chief Executive Officer/Founder, Mark Cuban Cost Plus Drug Company; Anthony Sardella, Chair, API Innovation Center, and Adjunct Professor and Senior Research Advisor, Center for Analytics and Business Insights, Washington University in St. Louis; Laura Bray, Founder and Chief Change Maker, Angels for Change; Fernando J. Muzzio, Ph.D., Distinguished Professor of Chemical and Biochemical Engineering and Director, NSF Engineering Research Center on Structured Organic Particulate Systems, Rutgers University.;

518 a| Date of hearing: 2023-05-11.;

588 a| Description based on online resource, PDF version; title from title page (GovInfo, viewed Aug. 20, 2024).;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

610 10 a| United States.b| Food and Drug Administrationv| Rules and practice.=| ^A1253;

650 0 a| Generic drugsx| Pricesz| United States.=| ^A434409;

650 0 a| Prescription pricingz| United States.=| ^A5242;

650 0 a| Drugsz| United Statesx| Generic substitution.=| ^A640;

650 0 a| Business logistics.0| https://id.loc.gov/authorities/subjects/sh85018306=| ^A115723;

650 0 a| Patent medicinesx| Law and legislationz| United States.=| ^A854852;

650 7 a| Health.2| cgpa;

650 7 a| Commerce.2| cgpa;

655 7 a| Legislative hearings.2| lcgft0| https://id.loc.gov/authorities/genreForms/gf2013025047;

776 08 i| Print version:a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.t| Examining the root causes of drug shortagesw| (OCoLC)1452768206;

856 40 u| https://purl.fdlp.gov/GPO/gpo2320327| 0;

922 a| BIBCONEWb| 20240820;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6472334;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6472334-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 9/13/2024x| EDOCUMENTz| JERESOURCE;

Examining the root causes of drug shortages : challenges in pharmaceutical drug supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, May 11, 2023.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2024.
Description	1 online resource (v, 88 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo232032
Subjects	United States. Food and Drug Administration--Rules and practice. Generic drugs--Prices. --United States. Prescription pricing--United States. Drugs--United States. --Generic substitution. Business logistics. Patent medicines--Law and legislation. --United States.

General note	"Serial no. 118-35."
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Alex Oshmyansky, M.D., Ph.D., Chief Executive Officer/Founder, Mark Cuban Cost Plus Drug Company; Anthony Sardella, Chair, API Innovation Center, and Adjunct Professor and Senior Research Advisor, Center for Analytics and Business Insights, Washington University in St. Louis; Laura Bray, Founder and Chief Change Maker, Angels for Change; Fernando J. Muzzio, Ph.D., Distinguished Professor of Chemical and Biochemical Engineering and Director, NSF Engineering Research Center on Structured Organic Particulate Systems, Rutgers University.
Date/time/place of a event note	Date of hearing: 2023-05-11.
Source of description	Description based on online resource, PDF version; title from title page (GovInfo, viewed Aug. 20, 2024).
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Examining the root causes of drug shortages
Genre/form	Legislative hearings.
Standard identifier#	55-967 (GPO jacket number)
Technical rpt number	Serial no. 118-35 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:118-35

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Examining the root causes of drug shortages : challenges in pharmaceutical drug supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, May 11, 2023.

Click here for more information about this title

Availability